Trademark: AMBLYOTAB
Put your brand on the blockchain and timestamp its proof of existence at wikitrademarks.io
Mark Identification
Proof of use for AMBLYOTAB
We do not have any records of a proof of use for AMBLYOTAB at this moment.
Possible trademark infringements of AMBLYOTAB
Basic Information about AMBLYOTAB
- Serial Number
- 97439848
- Filing Date
- 02 Jun 2022
- Mark Drawing Code
- 4
Classifications
Declare the trademark use of AMBLYOTAB on the blockchain with WikiTrademarks.io.
- First use of AMBLYOTAB anywhere
- No first use declared yet.
- First use in commerce
- There is no first use of this trademark in commerce detected yet.
- Status Code
- 6
- International Code
- 009
- US Codes
- 021; 023; 026; 036; 038
- First use of AMBLYOTAB anywhere
- No first use declared yet.
- First use in commerce
- There is no first use of this trademark in commerce detected yet.
- Status Code
- 6
- International Code
- 010
- US Codes
- 026; 039; 044
- First use of AMBLYOTAB anywhere
- No first use declared yet.
- First use in commerce
- There is no first use of this trademark in commerce detected yet.
- Status Code
- 6
- International Code
- 042
- US Codes
- 100; 101
- First use of AMBLYOTAB anywhere
- No first use declared yet.
- First use in commerce
- There is no first use of this trademark in commerce detected yet.
- Status Code
- 6
- International Code
- 044
- US Codes
- 100; 101
Who owns AMBLYOTAB?
1. Novartis AG Basel
2. Novartis AG Basel
Correspondent
- Maury M. Tepper, III TEPPER & EYSTER, PLLC
- 3724 BENSON DR
- RALEIGH, NC 27609-7321
- United States
Put your brand on the blockchain and timestamp its proof of existence at Wikitrademarks.io